National Taiwan University Hospital: Communicable Diseases trials

The registry lists 26 Communicable Diseases studies with National Taiwan University Hospital as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 3 1Phase 4 9No phase 16(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Comparison of Vonoprazan-based Versus Lansoprazole-based Triple Therapy, High Dose Dual Therapy, Bismuth and Non-bismuth Quadruple Therapy in the First-line Treatment of Helicobacter Pylori InfectionRecruitingNCT04713670Phase 4
• The Association Between Chlorhexidine Bathing and Central Line-Associated Infections in Medical Intensive Care UnitsCompletedNCT05919966
• Chlorhexidine to Prevent Catheter-related Urinary Tract InfectionCompletedNCT05712434Not applicable
• Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) for Patients With Hepatitis C Virus InfectionStatus unknownNCT05092074
• Probiotic Supplementation in the Dysbiosis of Bowel PreparationStatus unknownNCT04774042Not applicable
• HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral TherapyStatus unknownNCT04768517
• HCV Reinfection in HD Patients Achieving SVRStatus unknownNCT04732832
• Using Telemedicine to Optimize Teamwork and Infection Control of Critical and Highly-infectious Patients in an Emergency DepartmentCompletedNCT04591873
• Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV InfectionStatus unknownNCT03854630Phase 4
• The Impact of Antibiotics MIC Value on the Efficacy of Treatment Regimens for Helicobacter Pylori Infection.Status unknownNCT03583476
• Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for Rescue Treatment of Hp InfectionCompletedNCT02490839Phase 4
• Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for First-line Treatment of Hp InfectionCompletedNCT02483715Phase 4
• Efficacy of Acetylcysteine-containing Triple Therapy in the First Line of Helicobacter Pylori InfectionStatus unknownNCT02249546Phase 4
• Pseudomonal Type Three Secretion System and Contact Lens Associated Microbial KeratitisStatus unknownNCT01925846
• Triple Therapy Versus Quadruple Therapies in the First Line Therapy of Helicobacter Pylori InfectionStatus unknownNCT01906879Phase 4
• 48 Hours After Surgery Shower Patient's Wound Infection Rate, Pain Score, Patient Satisfaction and Cost.CompletedNCT01846598
• Effects of Activity and Education Program on Patients With Chronic Hepatitis C InfectionStatus unknownNCT01572233Not applicable
• Comparing Two Preventive Regimens for Latent Tuberculosis Infection (LTBI)Status unknownNCT01398618Phase 3
• Spatial Epidemiology of HIV InfectionCompletedNCT01377272
• The Efficacy of Susceptibility Test -Driven Sequential Therapy as the Third Line Therapy for Refractory Helicobacter Pylori InfectionCompletedNCT01032655Phase 4
• Serum Inflammatory Marker in Patients With Diagnosis of Nontuberculous Mycobacterial Pulmonary InfectionCompletedNCT00942916
• The Efficacy of Sequential Therapy as Second Line Therapy for Refractory Helicobacter Pylori Infection - A Pilot StudyCompletedNCT00885417Phase 4
• Relation of Metabolic Rate of Omeprazole and Eradication of Helicobacter Pylori InfectionCompletedNCT00854451Phase 4
• Long Term Outcomes of EV71 CNS InfectionStatus unknownNCT00172393
• The Role of CYP2C19 on the Eradication of H. Pylori Infection:Implication of PK/PD RelationshipsStatus unknownNCT00162877Not applicable
• Establish Epidemiologic Data of H. Pylori Infection in Children and Adolescents-Using C13-UBTCompletedNCT00155623